BEVERLY HILLS, Calif., Oct. 6, 2011 /PRNewswire/ -- Facial Plastic Surgeon, Davis B. Nguyen, MD is pleased with this week's announcement by Baxter Pharmaceuticals that ARTISS Fibrin Sealant has been approved by the FDA for use in facelifts. Dr. Nguyen was one of seven prominent plastic surgeons in the country who, in 2010, conducted the Phase 3 clinical trials to prove the benefits of using fibrin glue in facelifts. http://www.drdavisnguyen.com/
"The FDA approval confirms that Fibrin Glue is a groundbreaking product that makes facelift surgery much more comfortable for patients," states Dr. Nguyen. Recovery is more comfortable because drains, normally left in the face for 48 hours after surgery, are eliminated. "Another significant benefit of using Fibrin Glue is its effect on recovery time," notes Dr. Nguyen. "Patients heal nearly twice as fast."
According to the Baxter release, "The multi-center, prospective, randomized phase III clinical study was performed on 75 patients. The study compared the total drainage volume, collected in a standardized manner, for each side of the face at 24 hours post-surgery using a split-face study design, in which one side of the patient's face was sutured, per standard of care, while the other received the ARTISS fibrin sealant. The results showed the side sealed by Fibrin Glue swelled and bruised dramatically less; Patients experienced substantially less discomfort."
Always the innovator, Dr. Nguyen is presently conducting independent clinical research trials to demonstrate the efficacy and wound healing benefits of the use of fibrin glue in the endoscopic browlift procedure. Dr. Nguyen is one of only a few plastic surgeons in the country to offer this ground breaking innovation of combining the minimall